Paul W. Hoelscher - Apr 1, 2024 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Stock symbol
SGMT
Transactions as of
Apr 1, 2024
Transactions value $
$0
Form type
4
Date filed
4/3/2024, 08:17 PM
Previous filing
Jun 8, 2023
Next filing
Jun 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGMT Stock Option (Right to Buy) Award $0 +73K $0.00 73K Apr 1, 2024 Series A Common Stock 73K $5.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable over thirty-six (36) equal monthly installments following April 1, 2024, subject to the Reporting Person's continued service on each such vesting date.